Outlook and insights
In a continuous manner we make analyses and reports on relevant topics for the development and growth of life science.
Patient empowerment through digital health in Sweden
– Karlijn van Herpen – Jan 2021
Digital health is becoming more and more relevant over the past few years, also in Sweden. In recent years, Sweden has been working towards its vision for eHealth for 2025. In this vision, it is described that Sweden aims to be a world leader in 2025 when it comes to utilizing digital tools within the healthcare system. When it comes to digital health, the term patient empowerment is often mentioned as well. Mostly, the goal of all these digital tools is to create better healthcare for patients, where they are more in control of managing their disease.
Innovation strategies in Life science
– Arnau Requena Fernandez and Tina Sayari Mamaghani – Jun 2020
A successful innovation strategy is a key element in companies. To keep up with the rapid advancements in science and technology, companies need to use all their expertise; and many times, external aid, to stay competitive. Innovation can take place in product development and also in business development such as new profit models.
State of the Swedish Innovation Support System 2020
– Tuomas Väisänen – Jan 2020
There are a need and necessity for a country to be successful with innovation in order to achieve sustained growth. This sustained growth can either be achieved through the growth of already established companies or through the creation of new ones. Since roughly half of new employment is attributed to small and medium-sized enterprises (SMEs) creating jobs broadly across sectors, the wellbeing of the sector is essential. The fact highlights the necessity of entrepreneurship being a driver of regional growth. These statements hold true for a variety of different sectors.
Suppliers to Life science in Uppsala
– Pär Lindquist and Helen Andreasson, WSP – 2019
The results from this study indicate that a viable supplier sector based in Uppsala can in many ways be said to benefit innovation, renewal and dynamics in the Life Science sector. The suppliers contribute to strengthening the competitiveness of both large companies and the smaller fast-growing companies. This is both by increasing the ability to adapt and the opportunity to adapt to the economic situation, but also by providing expert competence and knowledge that is critical for companies’ development.
(The report is written in Swedish)